Stay updated with breaking news from Agrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a report published on Wednesday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Stock Performance Shares of NASDAQ AGRX opened at $6.98 on Wednesday. Agile Therapeutics has a fifty-two week low of $6.42 and a fifty-two […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) was the target of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 7,500 shares, a decline of 96.7% from the March 15th total of 225,700 shares. Based on an average daily volume of 17,000 shares, the […]
StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a report issued on Tuesday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Stock Performance Shares of NASDAQ AGRX opened at $0.23 on Tuesday. Agile Therapeutics has a fifty-two week low of $0.18 and a […]
StockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a research report report published on Monday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Price Performance NASDAQ AGRX opened at $0.23 on Monday. The company has a market capitalization of $10.79 million, a PE ratio […]
StockNews.com initiated coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a note issued to investors on Monday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Price Performance AGRX stock opened at $0.22 on Monday. The company has a market cap of $10.29 million, a P/E ratio […]